Bay City Capital News December 10, 2019 Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis
Uncategorized September 26, 2019 David Beier Op-Ed: A Plan to Address California’s Quiet Crisis: Children’s Mental Health
Uncategorized September 25, 2019 Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acquisition of ATXCo and Its Autotaxin Inhibitor (PAT-409)
Portfolio News August 27, 2019 Synchronicity Pharma Highlights New Research Demonstrating Beneficial Effects of Modulating Core Clock Proteins in Glioblastoma Stem Cells
Portfolio News June 27, 2019 Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
Uncategorized March 19, 2019 David Beier Op-Ed: FDA Reform: It’s Time To Act, But Not As An Independent Agency
Uncategorized January 25, 2019 David Beier Op-Ed: The Midterm’s Biggest Winners: Medicaid And Rural America
Uncategorized January 4, 2019 Artificial Intelligence keeps Gov.-elect Newsom up at night. Here’s what he can do about it
Uncategorized November 26, 2018 David Beier Op-Ed: How business leaders of the world can unite to end the trade war if the US and China are not up to the task
Portfolio News October 12, 2018 Dermira Provides Launch Readiness Update for QBREXZA™ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis